Author Information
Ralf Bartenschlager is a prominent researcher in the field of infectious diseases, currently affiliated with several esteemed institutions in Heidelberg, Germany. These include the Department of Infectious Diseases, Molecular Virology at Heidelberg University, the Division of Virus-Associated Carcinogenesis at the German Cancer Research Center (DKFZ), the HBIGS graduate school, and the German Centre for Infection Research (DZIF) at the Heidelberg partner site. His multidisciplinary affiliations highlight his comprehensive involvement in virology and infectious disease research.Research Contributions
Ralf Bartenschlager has made significant contributions to the study of infectious diseases, with a particular focus on virus-related research. In 2022, his work spanned a variety of topics, including imaging techniques for tracking particle movement in microscopy, structural changes induced by SARS-CoV-2, and the synergistic effects of drugs like Cobicistat and Remdesivir in inhibiting SARS-CoV-2 replication. He has also explored the neutralizing antibody activity against COVID-19 variants, examined the integrated stress response, and investigated hepatitis C virus pathogenesis. His research is instrumental in understanding viral mechanisms and developing therapeutic strategies.Aliases
Throughout his career, Ralf Bartenschlager has been referenced under several aliases, including "Ralf F. W. Bartenschlager," "Ralf F W Bartenschlager," "R. Bartenschlager," and "R Bartenschlager." These variations are commonly seen in academic publications and databases.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
48,172 |
| h-index |
117 |
| Total Paper Count |
599 |
